Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 24743055)

1.

Comparative proteomic analysis reveals unique tumor protein composition among the melanoma subtypes pure desmoplastic and superficial spreading.

Schowalter MK, Dulmage BO, Ho J, Vu JR, Falo LD Jr, Geskin LJ.

Melanoma Res. 2014 Aug;24(4):397-400. doi: 10.1097/CMR.0000000000000070.

PMID:
24743055
2.

Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.

Wagner JD, Ranieri J, Evdokimow DZ, Logan T, Chuang TY, Johnson CS, Jung SH, Wenck S, Coleman JJ 3rd.

Plast Reconstr Surg. 2003 Aug;112(2):486-97.

PMID:
12900606
3.

Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodes.

Satzger I, Völker B, Meier A, Schenck F, Kapp A, Gutzmer R.

Am J Surg Pathol. 2007 Aug;31(8):1175-80.

PMID:
17667539
4.

Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome.

Flørenes VA, Maelandsmo GM, Faye R, Nesland JM, Holm R.

J Pathol. 2001 Dec;195(5):530-6.

PMID:
11745687
5.

Incidence of sentinel lymph node involvement in a modern, large series of desmoplastic melanoma.

Egger ME, Huber KM, Dunki-Jacobs EM, Quillo AR, Scoggins CR, Martin RC 2nd, Stromberg AJ, McMasters KM, Callender GG.

J Am Coll Surg. 2013 Jul;217(1):37-44; discussion 44-5. doi: 10.1016/j.jamcollsurg.2013.05.006.

PMID:
23791271
6.

Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node.

Cochran AJ, Wen DR, Huang RR, Wang HJ, Elashoff R, Morton DL.

Mod Pathol. 2004 Jul;17(7):747-55.

7.

Desmoplastic melanoma: a 12-year experience with sentinel lymph node biopsy.

Broer PN, Walker ME, Goldberg C, Buonocore S, Braddock DT, Lazova R, Narayan D, Ariyan S.

Eur J Surg Oncol. 2013 Jul;39(7):681-5. doi: 10.1016/j.ejso.2013.02.025. Epub 2013 Mar 22.

PMID:
23522951
8.

High expression of glycolytic and pigment proteins is associated with worse clinical outcome in stage III melanoma.

Falkenius J, Lundeberg J, Johansson H, Tuominen R, Frostvik-Stolt M, Hansson J, Egyhazi Brage S.

Melanoma Res. 2013 Dec;23(6):452-60. doi: 10.1097/CMR.0000000000000027.

PMID:
24128789
9.

[Sentinel lymph node biopsy in patients with melanoma].

Tomás-Mallebrera L, Rojo-España R, Marquina-Vila A, Gimeno-Clemente N, Morales-Suárez-Varela MM.

Actas Dermosifiliogr. 2010 Jun;101(5):428-36. Spanish.

PMID:
20525486
10.

Stratification of patients by melanoma cell adhesion molecule (MCAM) expression on the basis of risk: implications for sentinel lymph node biopsy.

Pearl RA, Pacifico MD, Richman PI, Wilson GD, Grover R.

J Plast Reconstr Aesthet Surg. 2008;61(3):265-71. Epub 2007 Jun 13.

PMID:
17569608
11.

Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.

Vitoux D, Mourah S, Kerob D, Verola O, Basset-Seguin N, Baccard M, Schartz N, Ollivaud L, Archimbaud A, Servant JM, Revol M, Toubert ME, Podgorniak MP, Plassa F, Porcher R, Lebbé C.

Arch Dermatol. 2009 Oct;145(10):1105-13. doi: 10.1001/archdermatol.2009.209.

PMID:
19841396
12.

Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes.

Dadras SS, Lange-Asschenfeldt B, Velasco P, Nguyen L, Vora A, Muzikansky A, Jahnke K, Hauschild A, Hirakawa S, Mihm MC, Detmar M.

Mod Pathol. 2005 Sep;18(9):1232-42.

13.

Prognostic factors in cutaneous desmoplastic melanoma: a study of 252 patients.

Murali R, Shaw HM, Lai K, McCarthy SW, Quinn MJ, Stretch JR, Thompson JF, Scolyer RA.

Cancer. 2010 Sep 1;116(17):4130-8. doi: 10.1002/cncr.25148.

14.

Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.

Koskivuo I, Talve L, Vihinen P, Mäki M, Vahlberg T, Suominen E.

Ann Surg Oncol. 2007 Dec;14(12):3566-74. Epub 2007 Oct 9.

PMID:
17924169
15.

Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases.

Carlson JA, Dickersin GR, Sober AJ, Barnhill RL.

Cancer. 1995 Jan 15;75(2):478-94.

PMID:
7812919
16.

Sentinel node biopsy for head and neck desmoplastic melanoma: not a given.

Eppsteiner RW, Swick BL, Milhem MM, Hoffman HT, Pagedar NA.

Otolaryngol Head Neck Surg. 2012 Aug;147(2):271-4. doi: 10.1177/0194599812439857. Epub 2012 Mar 7.

PMID:
22399279
17.

Melastatin expression and prognosis in cutaneous malignant melanoma.

Duncan LM, Deeds J, Cronin FE, Donovan M, Sober AJ, Kauffman M, McCarthy JJ.

J Clin Oncol. 2001 Jan 15;19(2):568-76.

PMID:
11208852
18.

Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis.

Spanknebel K, Coit DG, Bieligk SC, Gonen M, Rosai J, Klimstra DS.

Am J Surg Pathol. 2005 Mar;29(3):305-17.

PMID:
15725798
19.

Desmoplastic melanoma: is there a role for sentinel lymph node biopsy?

Han D, Zager JS, Yu D, Zhao X, Walls B, Marzban SS, Rao NG, Sondak VK, Messina JL.

Ann Surg Oncol. 2013 Jul;20(7):2345-51. doi: 10.1245/s10434-013-2883-z. Epub 2013 Feb 7.

PMID:
23389470
20.

Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma.

Blaheta HJ, Ellwanger U, Schittek B, Sotlar K, MacZey E, Breuninger H, Thelen MH, Bueltmann B, Rassner G, Garbe C.

J Invest Dermatol. 2000 Apr;114(4):637-42.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk